After setting aside nearly $10 billion to settle over 125,000 claims from victims who alleged that Bayer’s flagship weed killer Roundup gave them cancer, the corporation has set aside another $2 billion for those whose cancer has not yet been diagnosed, but could be attributed to exposure to the product.
News of the agreement arrived in the first days of February and largely closes ...
continue reading...